MoneyWorks4Me

Zydus Lifesciences informs about transcript of earnings call

18 Aug 2023 Evaluate

Pursuant to Regulations 30 and 46(2) (oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zydus Lifesciences has informed that it attached the Transcript of the Company’s Q1 FY24 post results earnings call held on August 11, 2023.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..